A proposed rule to limit rebates paid by drug companies to pharmacy benefit managers (PBMs) could negatively impact physicians, payers and patients.
Dea Belazi
Advertisement
Articles by Dea Belazi
Advertisement
Latest Updated Articles
Eliminating pharma rebates will raise costs for physicians and payersPublished: May 29th 2019 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
Physicians taking back medicine: The rising toll of private equity in health care
2
Osteopathic medical schools train physicians — and create a $6B economic effect
3
Are ABMS’ lobbying tactics misleading politicians and the public?
4
$24M Medicare kickback scheme; 19 cookware items flagged for dangerous lead levels; monkey see, monkey free – Morning Medical Update
5
